Version 1
: Received: 14 July 2024 / Approved: 15 July 2024 / Online: 15 July 2024 (10:45:22 CEST)
How to cite:
Sallam, M.; Kherfan, T.; Al-Farajat, A.; Nemrawi, L.; Atawneh, N.; Fram, R.; Al-Tammemi, A. B.; Barakat, M.; Fram, K. Attitude to RSV Vaccination among a Cohort of Pregnant Women in Jordan. Preprints2024, 2024071151. https://doi.org/10.20944/preprints202407.1151.v1
Sallam, M.; Kherfan, T.; Al-Farajat, A.; Nemrawi, L.; Atawneh, N.; Fram, R.; Al-Tammemi, A. B.; Barakat, M.; Fram, K. Attitude to RSV Vaccination among a Cohort of Pregnant Women in Jordan. Preprints 2024, 2024071151. https://doi.org/10.20944/preprints202407.1151.v1
Sallam, M.; Kherfan, T.; Al-Farajat, A.; Nemrawi, L.; Atawneh, N.; Fram, R.; Al-Tammemi, A. B.; Barakat, M.; Fram, K. Attitude to RSV Vaccination among a Cohort of Pregnant Women in Jordan. Preprints2024, 2024071151. https://doi.org/10.20944/preprints202407.1151.v1
APA Style
Sallam, M., Kherfan, T., Al-Farajat, A., Nemrawi, L., Atawneh, N., Fram, R., Al-Tammemi, A. B., Barakat, M., & Fram, K. (2024). Attitude to RSV Vaccination among a Cohort of Pregnant Women in Jordan. Preprints. https://doi.org/10.20944/preprints202407.1151.v1
Chicago/Turabian Style
Sallam, M., Muna Barakat and Kamil Fram. 2024 "Attitude to RSV Vaccination among a Cohort of Pregnant Women in Jordan" Preprints. https://doi.org/10.20944/preprints202407.1151.v1
Abstract
The recently approved maternal vaccination against respiratory syncytial virus (RSV) can reduce its burden among infants. Vaccine hesitancy/resistance can undermine the beneficial impact of RSV vaccination. The aim of this study was to assess the willingness of pregnant women in Jordan to receive RSV vaccination and its associated determinants. Face-to-face interviews were conducted in obstetrics/gynecology clinics in Jordan during January-February 2024, with convenience sampling. Attitude to RSV vaccination was assessed using the previously validated ABCDEF scale. A total of 404 pregnant women participated in the study with a mean age of 30 years. A majority of the participants showed willingness to receive RSV vaccination (n=313, 77.5%), with hesitancy among 25 participants (6.2%), and resistance among 66 participants (16.3%). Variables that were signifi-cantly associated with a higher RSV vaccine acceptance in multivariate analysis were: age
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.